U.S. Court of Appeals for the Federal Circuit, 2025

Medivis, Inc. v. Novarad Corp.

Medivis, Inc. v. Novarad Corp.
U.S. Court of Appeals for the Federal Circuit · Decided December 10, 2025
Medivis, Inc. v. Novarad Corp.

Opinion

Case: 24-1951 Document: 41 Page: 1 Filed: 12/10/2025

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ MEDIVIS, INC.,

Appellant v.

NOVARAD CORP.,

Appellee ______________________ 2024-1951 ______________________ Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2023- 00045. ______________________ JUDGMENT ______________________ ADAM STEINMETZ, Desmarais LLP, Washington, DC, argued for appellant. Also represented by BETTY H. CHEN, San Francisco, CA; TAEG SANG CHO, JOHN M. DESMARAIS, New York, NY.

JOSEPH HARMER, Thorpe North & Western, LLP, Salt Lake City, UT, argued for appellee. Also represented by JED H. HANSEN. ______________________ Case: 24-1951 Document: 41 Page: 2 Filed: 12/10/2025

THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (PROST, CLEVENGER, and TARANTO, Cir- cuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

December 10, 2025

Date

Case-law data current through September 30, 2026. Source: CourtListener bulk data.